International Clinical Trial: Testing BMS 986504 combined with nab-p/gemcitabine chemotherapy or nab-p/gemcitabine chemotherapy alone in people with newly diagnosed metastatic pancreatic cancer with MTAP gene loss

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (CTRI/2026/09/116965) titled 'Testing BMS 986504 combined with nab-p/gemcitabine chemotherapy or nab-p/gemcitabine chemotherapy alone in people with newly diagnosed metastatic pancreatic cancer with MTAP gene loss' on Sept. 3.

Study Type: Interventional

Study Design: Randomized, Parallel Group, Placebo Controlled Trial Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:Centralized Blinding and masking:Participant and Investigator Blinded

Primary Sponsor: Bristol Myers Squibb Company

Condition: Health Condition 1: C253- Malignant neoplasm of pancreatic duct

Intervention: ...